Brexpiprazole for the treatment of schizophrenia: A review of this novel serotonin-dopamine activity modulator

Medicine & Life Sciences

• brexpiprazole 100%
• Serotonin 46%
• Dopamine 45%
• Schizophrenia 44%
• Placebos 22%
• Numbers Needed To Treat 13%
• Therapeutics 8%
• Serotonin 5-HT1 Receptor Antagonists 7%
• Body Weight 7%
• Aripiprazole 7%
• Psychomotor Agitation 6%
• Receptor, Serotonin, 5-HT1A 6%
• Dopamine Agonists 6%
• Major Depressive Disorder 5%
• United States Food and Drug Administration 5%
• Prolactin 5%
• Adrenergic Agents 5%
• Weight Gain 4%
• Antipsychotic Agents 4%
• Electrocardiography 4%
• Appointments and Schedules 4%
• Alzheimer Disease 4%
• Randomized Controlled Trials 3%
• Lipids 3%
• Weights and Measures 3%
• Glucose 3%
• Safety 3%
• Incidence 2%